Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models
- PMID: 21045154
- PMCID: PMC5555163
- DOI: 10.1158/0008-5472.CAN-10-0360
Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models
Abstract
Phosphocholine (PC) and total choline (tCho) are increased in malignant breast tumors. In this study, we combined magnetic resonance spectroscopic imaging (MRSI), mass spectrometry (MS) imaging, and pathologic assessment of corresponding tumor sections to investigate the localization of choline metabolites and cations in viable versus necrotic tumor regions in the nonmetastatic MCF-7 and the highly metastatic MDA-MB-231 breast cancer xenograft models. In vivo three-dimensional MRSI showed that high tCho levels, consisting of free choline (Cho), PC, and glycerophosphocholine (GPC), displayed a heterogeneous spatial distribution in the tumor. MS imaging performed on tumor sections detected the spatial distributions of individual PC, Cho, and GPC, as well as sodium (Na+) and potassium (K+), among many others. PC and Cho intensity were increased in viable compared with necrotic regions of MDA-MB-231 tumors, but relatively homogeneously distributed in MCF-7 tumors. Such behavior may be related to the role of PC and PC-related enzymes, such as choline kinase, choline transporters, and others, in malignant tumor growth. Na+ and K+ colocalized in the necrotic tumor areas of MDA-MB-231 tumors, whereas in MCF-7 tumors, Na+ was detected in necrotic and K+ in viable tumor regions. This may be attributed to differential Na+/K+ pump functions and K+ channel expressions. Principal component analysis of the MS imaging data clearly identified different tumor microenvironmental regions by their distinct molecular signatures. This molecular information allowed us to differentiate between distinct tumor regions and tumor types, which may, in the future, prove clinically useful in the pathologic assessment of breast cancers.
Copyright © 2010 AACR.
Figures





Similar articles
-
Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.Anal Cell Pathol (Amst). 2013;36(3-4):71-83. doi: 10.3233/ACP-130082. Anal Cell Pathol (Amst). 2013. PMID: 24036926 Free PMC article.
-
Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.Magn Reson Med. 2007 Aug;58(2):270-80. doi: 10.1002/mrm.21333. Magn Reson Med. 2007. PMID: 17654590
-
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.Breast Cancer Res. 2014 Jan 21;16(1):R5. doi: 10.1186/bcr3597. Breast Cancer Res. 2014. PMID: 24447408 Free PMC article.
-
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.Breast Cancer Res. 2010;12(5):R84. doi: 10.1186/bcr2729. Epub 2010 Oct 14. Breast Cancer Res. 2010. PMID: 20946630 Free PMC article.
-
Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.NMR Biomed. 2019 Oct;32(10):e4112. doi: 10.1002/nbm.4112. Epub 2019 Jun 11. NMR Biomed. 2019. PMID: 31184789 Free PMC article. Review.
Cited by
-
Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemia.J Lipid Res. 2012 Sep;53(9):1823-31. doi: 10.1194/jlr.M022558. Epub 2012 Jun 29. J Lipid Res. 2012. PMID: 22750654 Free PMC article.
-
Live-cell vibrational imaging of choline metabolites by stimulated Raman scattering coupled with isotope-based metabolic labeling.Analyst. 2014 May 21;139(10):2312-7. doi: 10.1039/c3an02281a. Analyst. 2014. PMID: 24555181 Free PMC article.
-
Lipid analysis of eight human breast cancer cell lines with ToF-SIMS.Biointerphases. 2015 Jun 28;11(2):02A303. doi: 10.1116/1.4929633. Biointerphases. 2015. PMID: 26319020 Free PMC article.
-
Cepharanthine hydrochloride inhibits prostate cancer progression by modulating gut microbiota and metabolites.Front Pharmacol. 2025 Aug 13;16:1627656. doi: 10.3389/fphar.2025.1627656. eCollection 2025. Front Pharmacol. 2025. PMID: 40880650 Free PMC article.
-
Correlated Materials Characterization via Multimodal Chemical and Functional Imaging.ACS Nano. 2018 Dec 26;12(12):11798-11818. doi: 10.1021/acsnano.8b07292. Epub 2018 Dec 3. ACS Nano. 2018. PMID: 30422627 Free PMC article.
References
-
- Bathen TF, Holmgren K, Lundemo AG, et al. Omega-3 fatty acids suppress growth of sw620 human colon cancer xenografts in nude mice. Anticancer Res. 2008;28:3717–23. - PubMed
-
- de Molina AR, Sormentero-Estrada J, Beldo-Iniesta C, et al. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: A retrospective study. Lancet Oncol. 2007;8:889–97. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous